|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
CELLEX BIOSCIENCES, INC.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-1-1999
<PERIOD-END> JUN-30-2000
<CASH> 1,498,000
<SECURITIES> 0
<RECEIVABLES> 1,576,000
<ALLOWANCES> 238,000
<INVENTORY> 1,813,000
<CURRENT-ASSETS> 5,432,000
<PP&E> 1,355,000
<DEPRECIATION> 52,000
<TOTAL-ASSETS> 10,842,000
<CURRENT-LIABILITIES> 2,276,000
<BONDS> 0
0
0
<COMMON> 9,203,000
<OTHER-SE> 1,155,000
<TOTAL-LIABILITY-AND-EQUITY> 10,842,000
<SALES> 3,743,000
<TOTAL-REVENUES> 3,743,000
<CGS> 2,334,000
<TOTAL-COSTS> 2,334,000
<OTHER-EXPENSES> 2,259,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 140,000
<INCOME-PRETAX> 957,000
<INCOME-TAX> 0
<INCOME-CONTINUING> 957,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 957,000
<EPS-BASIC> .25
<EPS-DILUTED> .25
</TABLE>
|
|